Joseph D. Ruether

4.4k total citations · 1 hit paper
54 papers, 3.2k citations indexed

About

Joseph D. Ruether is a scholar working on Oncology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Joseph D. Ruether has authored 54 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in General Health Professions. Recurrent topics in Joseph D. Ruether's work include Prostate Cancer Treatment and Research (13 papers), Patient-Provider Communication in Healthcare (11 papers) and Cancer survivorship and care (10 papers). Joseph D. Ruether is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Patient-Provider Communication in Healthcare (11 papers) and Cancer survivorship and care (10 papers). Joseph D. Ruether collaborates with scholars based in Canada, United States and India. Joseph D. Ruether's co-authors include Peter Venner, Kim N., Scott North, Christian Kollmannsberger, Bernhard J. Eigl, Daniel Y.C. Heng, Ronald M. Bukowski, Jennifer J. Knox, Mark Warren and Michael B. Atkins and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Joseph D. Ruether

54 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

2009 1.5k citations Daniel Y.C. Heng, Joseph D. Ruether et al. Journal of Clinical Oncology profile →

Peers

Joseph D. Ruether

PRM

ONCOL

SURGE

Pilar Garrido Spain

Craig Underhill Australia

Giannis Mountzios Greece

Huiying Sun China

Hyun-Joo Kong South Korea

Timothy D. Gilligan United States

Glenn Mills United States

M. Nooij Netherlands

James Khatcheressian United States

Jean Latreille Canada

Pilar Garrido Spain

Joseph D. Ruether

1.9k ×1.0

PRM

2.1k ×1.7

ONCOL

909 ×0.9

610 ×0.8

402 ×1.0

SURGE

Citations per year, relative to Joseph D. Ruether Joseph D. Ruether (= 1×) peers Pilar Garrido

Countries citing papers authored by Joseph D. Ruether

Since Specialization

Citations

This map shows the geographic impact of Joseph D. Ruether's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph D. Ruether with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph D. Ruether more than expected).

Fields of papers citing papers by Joseph D. Ruether

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph D. Ruether. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph D. Ruether. The network helps show where Joseph D. Ruether may publish in the future.

Co-authorship network of co-authors of Joseph D. Ruether

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph D. Ruether. A scholar is included among the top collaborators of Joseph D. Ruether based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph D. Ruether. Joseph D. Ruether is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yip, Steven, Michael Kolinsky, Kosuke Takemura, et al.. (2023). 1799P Real-world (RW) treatment (tx) patterns of metastatic prostate cancer (mPCa) with enhanced access to homologous recombination repair (HRR) genomic testing and poly ADP ribose polymerase inhibitor (PARPi). Annals of Oncology. 34. S972–S972. 1 indexed citations

Hack, Thomas F., Joseph D. Ruether, Marshall Pitz, et al.. (2021). Impact of consultation recordings on patient-reported outcomes in patients with brain tumors: a parallel randomized controlled trial. Supportive Care in Cancer. 29(10). 5681–5690. 6 indexed citations

Gotto, Geoffrey, Melissa Shea‐Budgell, & Joseph D. Ruether. (2016). Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta. Canadian Urological Association Journal. 10(1-2). 33–33. 12 indexed citations

North, Scott, Naveen S. Basappa, Joan Basiuk, et al.. (2015). Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update. Canadian Urological Association Journal. 9(5-6). 164–164. 12 indexed citations

Richter, Suzanne, Joseph D. Ruether, Lori Wood, et al.. (2013). Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Canadian Urological Association Journal. 7(11-12). 797–797. 11 indexed citations

Ho, Clement, Joseph D. Ruether, Bryan Donnelly, & Marc Kerba. (2013). A population-based study examining the impact of a multidisciplinary rapid access clinic on utilization of initial treatment options for patients with localized prostate cancer.. Journal of Clinical Oncology. 31(31_suppl). 15–15. 8 indexed citations

Hack, Thomas F., Linda E. Carlson, Lorna Butler, et al.. (2011). Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive care. Supportive Care in Cancer. 19(8). 1097–1105. 41 indexed citations

Allan, G. Michael, Michael Chetner, Bryan Donnelly, et al.. (2011). Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks). Canadian Urological Association Journal. 5(6). 416–421. 7 indexed citations

Hack, Thomas F., Joseph D. Ruether, Lorna Weir, Debjani Grenier, & Lesley F. Degner. (2011). Study protocol: Addressing evidence and context to facilitate transfer and uptake of consultation recording use in oncology: A knowledge translation implementation study. Implementation Science. 6(1). 20–20. 9 indexed citations

10.

Hack, Thomas F., Tom Pickles, Joseph D. Ruether, et al.. (2009). Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role. Psycho-Oncology. 19(6). 606–616. 73 indexed citations

11.

Hack, Thomas F., Tom Pickles, Joseph D. Ruether, et al.. (2009). Behind closed doors: systematic analysis of breast cancer consultation communication and predictors of satisfaction with communication. Psycho-Oncology. 19(6). 626–636. 39 indexed citations

12.

Ellard, Susan, Sébastien J. Hotte, Piotr Czaykowski, et al.. (2007). A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Annals of Oncology. 19(4). 746–751. 93 indexed citations

13.

Pickles, Tom, et al.. (2007). Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. British Journal of Urology. 100(3). 544–551. 88 indexed citations

14.

Beer, Tomasz M., Christopher W. Ryan, Peter Venner, et al.. (2007). Intermittent chemotherapy in patients with metastatic androgen‐independent prostate cancer. Cancer. 112(2). 326–330. 78 indexed citations

15.

Pudney, Delia, Harold Lau, Joseph D. Ruether, & Vincent Falck. (2007). Clinical Experience of the Multimodality Management of Anaplastic Thyroid Cancer and Literature Review. Thyroid. 17(12). 1243–1250. 21 indexed citations

16.

Beer, Tomasz M., Peter Venner, Christopher W. Ryan, et al.. (2006). High dose calcitriol may reduce thrombosis in cancer patients. British Journal of Haematology. 135(3). 392–394. 63 indexed citations

17.

Stewart, Douglas A., Alexander Paterson, Joseph D. Ruether, et al.. (2005). High-dose mitoxantrone–vinblastine–cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study. Annals of Oncology. 16(9). 1463–1468. 6 indexed citations

18.

Russell, Jeffrey A., Hai T. Tran, Diana Quinlan, et al.. (2002). Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes. Biology of Blood and Marrow Transplantation. 8(9). 468–476. 220 indexed citations

19.

Russell, JA, A Chaudhry, Karen Booth, et al.. (2000). Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience. Biology of Blood and Marrow Transplantation. 6(2). 109–114. 50 indexed citations

20.

Jones, Ashley, Joseph D. Ruether, & Bernard A. Ruether. (1988). Staging laparotomy in Hodgkin's disease: A community hospital experience. Journal of Surgical Oncology. 38(4). 217–220. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact